• the past;former times
昔
[xī]
  • 以前,从前:~者。~人。往~。今~对比。

  • 古同“夕”,夜。

[xī]
[名]
1

(从前; 过去) former times; the past:

  • 往昔

    in the past; in former times;

  • 今昔对比

    contrast the past with the present;

  • 今胜于昔。

    The present is superior to the past.

2

(姓氏) a surname:

  • 昔登

    Xi Deng

  1. 饶恕不能调动夙昔,但能拓宽将来。

    Forgiveness does not change the past , but it does enlarge the future .

  2. 时光无法倒流,我们都不可能回到昔时。

    Time never moves in reverse , so we can never relive the past .

  3. 今胜于昔。

    The present is superior to the past .

  4. 昔时恩爱已成追忆。

    The love of yore now exists only in the memory .

  5. 昔时,骑士通常身穿一整套盔甲。

    In the days of yore it was usual for cavalrymen to wear suits of armour .

  6. 昔时的坐骑,如今却要将你毁灭

    That which once you rode annihilates you .

  7. 利妥昔单抗联合化疗方案治疗B细胞淋巴瘤

    Treatment of B-cell Lymphoma with the Regimen of Rituximab Combined Chemotherapy

  8. pH指示剂吸光度比法测定喷昔洛韦钠原料药含量

    Determination of Penciclovir Sodium by pH - Indicator Absorbance Ratio Method

  9. 吲哚美辛和美洛昔康对脂多糖诱导的小鼠腹腔巨噬细胞NF-κB的抑制作用

    Inhibitory effects of indomethacin and meloxicam on nf - κ b in mouse peritoneal macrophages

  10. 利妥昔单抗联合化疗治疗弥漫型大B细胞淋巴瘤的临床观察

    Clinical observation on rituximab combined with chemotherapy in the treatment of diffused large B cell lymphoma

  11. HPLC法测定血及组织中美洛昔康药物浓度

    Determination of Mel concentration in serum and local tissue by HPLC

  12. 2例B细胞非霍奇金淋巴瘤患者异基因造血干细胞移植联合利妥昔单抗治疗的护理

    Nursing Care for Patients with B-Cell Non-Hodgkin 's Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation Combined with Rituximab

  13. CHOP方案联合利妥昔单抗治疗弥漫大B细胞淋巴瘤

    CHOP chemotherapy plus rituximab for elderly patients with diffuse large-B-cell lymphoma

  14. 载脂蛋白E基因多态性与银屑病有关但不能预测疾病对阿昔曲丁的反应

    Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin

  15. 方法用MTT法测定屈洛昔芬对小鼠脑微血管内皮细胞bEnd。

    METHODS Growth inhibition of mice brain microvascular endothelial cells bEnd .

  16. HPLC法测定血清中替诺昔康浓度

    HPLC determination of tenoxicam in serum

  17. 在3~24h时间窗内采用阿昔单抗治疗缺血性卒中的MRI引导的开放性试验

    MRI-guided , open trial of abciximab for ischemic stroke within a 3-to 24-hour window

  18. HPLC法测定美洛昔康分散片的含量这些遗迹充分证明此处昔日的宏伟。

    Determination of Meloxicam Dispersible Tablets by HPLC These ruins sufficiently attest the former grandeur of the place .

  19. 结果:一年以后,利妥昔单抗组C肽水平的平均曲线下面积明显高于安慰机组。

    Results At1 year , the mean AUC for the level of C peptide was significantly higher in the rituximab group than in the placebo group .

  20. 目的:合成COX-2抑制剂戊地昔布。

    Objective : To synthesize valdecoxib , a COX-2 inhibitor .

  21. RP-HPLC法测定血浆中替诺昔康的浓度

    Determination of Tenoxicam in Plasma by RP-HPLC

  22. 预先给美洛昔康后LPS所致COX-2蛋白在大鼠脑内的表达

    Expression of LPS-induced Cyclooxygenase-2 Protein in the Rat Brain with Meloxicam Given Beforehand

  23. 美洛昔康凝胶治疗AA大鼠的疗效与局部药物浓度的关系研究

    The relationship between therapeutic effects and concentration in tissue or serum of Mel G

  24. 塞来昔布对Lewis肺癌的抑制作用

    Inhibitory effects of Celecoxib on Lewis lung carcinoma

  25. 结论泛昔洛韦治疗HBV慢性感染安全有效。

    Conclusion Famciclovir is an effective and safe nucleoside drug for the treatment of patients with chronic HBV infection .

  26. 美洛昔康治疗类风湿关节炎与骨关节炎的疗效及安全性Meta分析

    Efficacy and Safety of Meloxicam for Rheumatoid Arthritis and Osteoarthritis : A Meta-analysis

  27. COX-2抑制剂戊地昔布的合成

    Synthesis of valdecoxib , a COX-2 inhibitor

  28. 英夫利昔治疗溃疡性结肠炎疗效与安全性的meta分析

    The Efficacy and Safety of Infliximab in the Treatment of Ulcerative Colitis : A Meta-analysis

  29. RP-HPLC法测定美洛昔康片的含量

    Determination Method for Meloxicam Tablets by RP-HPLC

  30. 用抗CD20的单克隆抗体利妥昔单抗能够做到选择性的消耗B淋巴细胞。

    It is possible to achieve selective depletion of B lymphocytes with rituximab , an anti-CD20 monoclonal antibody .